Functional CRISPR Screens in T Cells Reveal New Opportunities for Cancer Immunotherapies

Investigators bridge the gap between discovering element genes to a specific process of T cell activities and apprehending these genes in the global T cell life cycle, deepened the understanding of T cell biology in tumour immunity, and outline CRISPR screens resources that might facilitate the development and implementation of cancer immunotherapies in the clinic.